Autopsy report · NCT00090688

Phase 1 meCS6 + LT(R192G) Vaccine Study

“IND was terminated for being inactive for more than five years”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

U.S. Army Medical Research and Development Command

Sponsor type

US federal agency

Conditions

Diarrhea

Interventions

meCS6 + LT(R192G)

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
  “terminated due to administrative reasons.” (66% match in meaning)
• Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP
  “Terminated due to no new subject enrollment during the last 3 year period.” (65% match in meaning)
• Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
  “Terminated due to inadequate rate of accrual.” (63% match in meaning)
• Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
  “Terminated due to lack of efficacy” (62% match in meaning)
• CA-125 in Screening Patients at High Risk for Ovarian Cancer
  “Terminated for administrative reasons and becuase there were no enrollments” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.